Laurus Bio

Laurus Bio Contract Manufacturing & Development (CDMO) Profile

A fully integrated biotech R&D and manufacturing organization with over 15 years of Biopharma experience. Our services span across the value chain from strain engineering, process development, scale up and large scale manufacturing. Laurus Bio is the biotech subsidiary of Laurus Labs, a publicly listed company with 7000 employees, $700M in revenues and 14 manufacturing sites.

CDMO Services:
API and/or Ingredients; Cell & Gene Therapy; Food Supplements Analytical Development; Cell Line Development; Process Development; Protein Synthesis Antibody-drug conjugate (ADC); Recombinants + other Proteins; mRNA Vaccines; Protein Vaccines; Plasmid DNA

Head Office: Bengaluru, India

Number of Facilities: 3-5

Facility locations: South Asia; South-East Asia

Website: Visit the Laurus Bio website

Linkedin: Connect on Linkedin

Current Capacity: 240,000L

Growing 20X in the next 5 years